These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5453084)
1. Treatment of leprosy with a phenazine derivative (B 663 or G 30 320)--clofazimine. Gatti JC; Cardama JE; Balina LM; Crespi HG; Bianchi O; Santabaya E; Farina MH Lepr Rev; 1970 Apr; 41(2):89-92. PubMed ID: 5453084 [No Abstract] [Full Text] [Related]
2. Clofazimine in leprosy. Schulz EJ Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339 [No Abstract] [Full Text] [Related]
3. The use of B 663 (clofazimine) in the treatment of Chinese leprosy patients with chronic reaction. Warren AG Lepr Rev; 1970 Apr; 41(2):74-82. PubMed ID: 5453082 [No Abstract] [Full Text] [Related]
4. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)). Morgan J Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679 [No Abstract] [Full Text] [Related]
5. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935 [TBL] [Abstract][Full Text] [Related]
6. Bacteriological effect of Lamprene (clofazimine) in lepromatous leprosy (report of one year's treatment of 44 patients with 100 mg of Lamprene daily). Leiker DL; Blenska W; Carling D; Fitzherbert M; Larssen P Lepr Rev; 1971 Jun; 42(2):125-30. PubMed ID: 4948481 [No Abstract] [Full Text] [Related]
8. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472 [No Abstract] [Full Text] [Related]
9. Clofazimine ointment in the treatment of trophic ulcers. Ellis BP; Taube E S Afr Med J; 1973 Mar; 47(9):378-9. PubMed ID: 4690398 [No Abstract] [Full Text] [Related]
10. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report. Devadason C Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239 [No Abstract] [Full Text] [Related]
11. Clinical evaluation of Lamprene (Geigy). A preliminary report. Karuru ER Lepr Rev; 1970 Apr; 41(2):83-8. PubMed ID: 5453083 [No Abstract] [Full Text] [Related]
12. Management of neuritis in leprosy. Pfaltzgraff RE Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065 [No Abstract] [Full Text] [Related]
13. Clofazimine in leprosy. Browne SG Br Med J; 1972 Feb; 1(5798):506-7. PubMed ID: 4550304 [No Abstract] [Full Text] [Related]
16. Activity of phenazine analogs against Mycobacterium leprae infections in mice. Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439 [TBL] [Abstract][Full Text] [Related]
17. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)). Schulz EJ Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819 [No Abstract] [Full Text] [Related]
18. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368 [No Abstract] [Full Text] [Related]